Crosstree Capital Partners Overview

  • Service
  • Investment Bank

  • Founded
  • 2004

Founded
  • Employees
  • 34

Employees
  • Serviced Companies
  • 111

  • Serviced Deals
  • 104

  • Serviced Investors
  • 20

Crosstree Capital Partners General Information

Description

Founded in 2004, Crosstree Capital Partners is a Tampa, Florida-based healthcare-focused investment banking firm. The firm works with companies involved in global research and development, and the commercialization of biopharmaceutical, diagnostic, and digital healthcare products and services. Crosstree specializes in advising clients on mergers and acquisitions, liquidations, divestitures, recapitalizations, add-on acquisitions, and capital-raising deals.

Contact Information

Year Founded
2004
Service Provider Type
Investment Bank
Primary Office
  • 2701 North Rocky Point Drive
  • Suite 925
  • Tampa, FL 33607
  • United States
+1 (813) 000-0000

Crosstree Capital Partners Services to Companies

Service on a Deal (104)

Company Name Service Provided Deal Date Deal Type Deal Amount
Grenova Advisor: Financial Due Diligence Mar 2022 00000 0000000
000 000000000 Advisor: General Jan 2022 00000 0000000
00000000 00000000 Advisor: General Jan 2022 00000 0000000
000000 00000000000 Advisor: General Jan 2022 00000 0000000
000000000000000000 Advisor: General Dec 2021 00000 0000000
000000 00000000 00 Advisor: General Dec 2021 00000 0000000
00000000 00000 Advisor: General Dec 2021 00000 0000000
000000000 (0000000 Advisor: General Dec 2021 00000 0000000
UpStream Advisor: General Nov 2021 00000 0000000
Pharmica Consulting Advisor: General Oct 2021 00000 0000000
You’re viewing 10 of 104 services to companies. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Crosstree Capital Partners Services to Investors

Service on a Deal — Buy Side (24)

Investor Name Service Provided Deal Date Deal Type Deal Amount
Clinical Trials of Texas Advisor: General Jan 2022 00000 0000000
000 0000000000 000 Advisor: General Jan 2022 00000 0000000
0.0.0. 0000000 Advisor: General Dec 2021 00000 0000000
00000000 000000 00 Advisor: General Oct 2021 00000 0000000
000000 0000 Advisor: General Jul 2021 00000 0000000
00000000 Advisor: General Jun 2021 00000 0000000
000000000 Advisor: General Jun 2021 00000 0000000
000000000 Advisor: General Jun 2021 00000 0000000
ArchiMed Advisor: General May 2021 00000 0000000
dMed Advisor: General Apr 2021 00000 0000000
You’re viewing 10 of 24 services on a deal — buy side. Get the full list »

Service on a Deal — Sell Side (7)

Investor Name Service Provided Deal Date Deal Type Deal Amount
GlaxoSmithKline Advisor: General Nov 2018 00000 0000000
000000 Advisor: General Oct 2018 00000 0000000
00000 00000 000000 Advisor: General Sep 2018 00000 0000000
0000000000 0000000 Advisor: General Aug 2018 00000 0000000
0000000000 0000000 Advisor: General Nov 2012 00000 0000000
Enthalpy Analytical Advisor: General Jun 2010 00000 0000000
Medifacts International Advisor: General Mar 2007 00000 0000000
To view Crosstree Capital Partners’s complete services on a deal — sell side history, request access »

Crosstree Capital Partners Investment Preferences

Preferred Industries Preferred Verticals Preferred Deal Types Geographic Preferences Transaction Amount

This information is available in the PitchBook Platform. To explore Crosstree Capital Partners‘s full profile, request access.

Request a free trial

Crosstree Capital Partners Team (28)

Name Title Deals Office Contact
Info
Jeff Ellis Co-Founder & Managing Director 0 Tampa, FL
Shane Senior Co-Founder & Managing Director 0 Tampa, FL
Ezequiel Navar Managing Director Tampa, FL
Gordon Ryerson Managing Director Tampa, FL
Stephen Dirkes Managing Director Tampa, FL
You’re viewing 5 of 28 team members. Get the full list »